Please Wait...

Reproducibility of a Semi-automatic Knee Joint Analysis Tool

*Yu HJ, *Zhang Y, *Morges S, *Dawson E, *Galante N, *Belaroussi B, **Hoover KB, *Miller CG.

*BioClinica, Inc., Newtown, PA 18940
**Department of Radiology, VCU Medical Center, Richmond, PA 23219

BACKGROUND: Minimal Joint Space Width (mJSW, defined as the narrowest point of the tibio-femoral joint), and Anatomical Axis Angle (AAA, the angle formed by the lines bisecting the femur and the tibia as they intersect at the center of the tibial spine tips on plain radiographs of the knee can be used to evaluate the severity and progression of knee osteoarthritis  These measurements are therefore useful in determining subject eligibility and safety in clinical trials for osteoarthritis treatment.  To be practical for clinical trials, an efficient, accurate and precise measurement system is required which also features the QC tool for Inter-margin-distance (IMD).
OBJECTIVE: To evaluate a new semi-automated knee joint analysis tool to measure mJSW, AAA and IMD for use in clinical trials.

METHODS: Both mJSW and AAA were automatically calculated with minimal user interactions (Figure 1 and 2), while IMD was measured using a built-in caliper. Both mJSW and AAA were measured on AP knee radiographs from 30 subjects, by two experienced users, to assess inter- and intra-observer reproducibility. The Mean (and SD) value of absolute difference in each measurement was computed. IMD precision was not evaluated in this study. The 30 radiographs were obtained from a previous OA trial and had a range of KL scores from 0 to 4.

RESULTS: Table 1 and 2 show both the intra- and inter-observer intraclass correlation coefficient (ICC) values as well as repeatability coefficients (RCs) for medial mJSW, lateral mJSW, and AAA.

mJSW

The intra-observer reproducibility of mJSW ranged from 0.95 to 0.99 for ICC and 0.36 to 0.64 mm for RC. The inter-observer reproducibility of mJSW ranged from 0.85 to 0.98 for ICC and 0.59 to 1.33 mm for RC.

AAA

The intra-observer ICC of AAA were 0.95 and 0.97 for observer A and B, respectively. The inter-observer ICC of AAA were 0.85 and 0.92 for session 1 and 2, respectively. The RCs ranged from 1.54o to 3.04o.

CONCLUSION: The analysis tool presented here provided good intra- and inter-observer reproducibility.  The constraints aided in the user a rapid identification of location and reproducible landmarks.  This comprehensive semi-automated analysis tool and is suitable for the assessment of knee joints in clinical trials.

SPONSOR: BioClinica Inc.

DICLOSURE STATEMENT: None

ACKNOWLEDGMENT: None

CORRESPONDENCE ADDRESS: colin.miller@bioclinica.com

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica SMART Our Digital Customer Portal Allows Sites and Sponsors to Benefit from Real-Time Access to Their Tr… https://t.co/VJi2kVttFu
Bioclinica (13 hours ago)
Bioclinica will be gold sponsors at the upcoming World Drug Safety Congress in Europe. Meeting with our team to le… https://t.co/7efqU3ZHb8
Bioclinica (2 days ago)
Bioclinica Cardiac Safety Services Offered a Unique Solution for a Specific Regulatory Requirement. Read our case s… https://t.co/4j1AUk6YDz
Bioclinica (5 days ago)
Agile IRT is here! How can you benefit? Download our webinar to know more. #bioclinica #irt #clinicaltrials… https://t.co/zH5aFYxxUf
Bioclinica (6 days ago)
Bioclinica's Electronic Data Capture #EDC has been used in thousands of clinical studies worldwide. Why? Our single… https://t.co/g427VOUSFS
Bioclinica (1 week ago)
Bioclinica will be exhibiting at the upcoming #SCDM2019 – the industry’s largest clinical data management event of… https://t.co/JLTSWOI8rl
Bioclinica (2 weeks ago)